{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:03Z","timestamp":1740126423701,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10354-018-0624-4","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T07:06:35Z","timestamp":1517900795000},"page":"193-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastische cerebell\u00e4re Degeneration (PCD) \u2013 eine interdisziplin\u00e4re Herausforderung in der Neurologie, Onkologie und Palliativmedizin","Paraneoplastic cerebellar degeneration (PCD)\u00a0\u2013 an interdisciplinary challenge in neurology, oncology and palliative care"],"prefix":"10.1007","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7157-8975","authenticated-orcid":false,"given":"Sabine","family":"Burger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Lorenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"624_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0733-8619(02)00037-3","volume":"21","author":"L Bataller","year":"2003","unstructured":"Bataller L, Dalmeau J. Paraneoplastic neurologic syndromes. Neurol Clin. 2003;21:221\u201347.","journal-title":"Neurol Clin"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1109653","volume":"366","author":"J Baselga","year":"2012","unstructured":"Baselga J, et al. Everolimus in postmenopausal hormone receptor-positive advanced breast cancer. N\u00a0Engl J Med. 2012;366:520\u20139.","journal-title":"N Engl J Med"},{"key":"624_CR3","doi-asserted-by":"publisher","first-page":"e27384","DOI":"10.4161\/onci.27384","volume":"2","author":"BS Pignolet","year":"2013","unstructured":"Pignolet BS, Gebauer CM, Liblau RS. Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: a beneficial antitumor immune response going awry. Oncoimmunology. 2013;2:e27384.","journal-title":"Oncoimmunology"},{"key":"624_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cellimm.2014.06.009","volume":"290","author":"L Zhang","year":"2014","unstructured":"Zhang L, Qian W, Chen Q, et al. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes. Cell Immunol. 2014;290:245\u201350. Studies supporting a\u00a0role for excessive activation of T cells and dysfunction of Treg in the pathogenesis of Hu-antibody associated PNS.","journal-title":"Cell Immunol"},{"key":"624_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a\u00a0case series, characterization of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13:276\u201386. Description of the clinical syndrome and pathogenic effects of the antibodies.","journal-title":"Lancet Neurol"},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/brain\/awu310","volume":"138","author":"J Planaguma","year":"2015","unstructured":"Planaguma J, Leypoldt F, Mannara F, et al. Human N\u2011methyl D\u2011aspartate receptor antibodies alter memory and behaviour in mice. Brain. 2015;138:94\u2013109. The first animal model of an autoimmune encephalitis providing a\u00a0link between memory and behavioural deficits and antibody-mediated reduction of NMDAR.","journal-title":"Brain"},{"issue":"6","key":"624_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/CCO.0000000000000222","volume":"27","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, Rosenfeld MR, Dalmau J. Update on neurological paraneoplastic syndromes. Curr Opin Oncol. 2015;27(6):489\u201395.","journal-title":"Curr Opin Oncol"},{"key":"624_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ygyno.2005.06.064","volume":"99","author":"Y Tanaka","year":"2005","unstructured":"Tanaka Y, Suzuki N, Takao M, Ichikawa A, Susumu N, Aoki D. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma. Gynecol Oncol. 2005;99:500\u20133.","journal-title":"Gynecol Oncol"},{"key":"624_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1479-828X.2005.00330.x","volume":"45","author":"R Land","year":"2005","unstructured":"Land R, Carter J, Houghton R, Atkinson K, Dalrymple C. Gynaecology meets neurology: paraneoplastic cerebellar degeneration. Aust N Z J Obstet Gynaecol. 2005;45:79\u201381.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"624_CR10","first-page":"476","volume":"13","author":"S Brock","year":"2001","unstructured":"Brock S, Ellison D, Frankel J, Davis C, Illidge T. Anti-Yo antibody-positive cerebellar degeneration associated with endometrial carcinoma: case report and review of the literature. Clin Oncol (R Coll Radiol). 2001;13:476\u20139.","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"624_CR11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody positive patients. Neurology. 1992;42:1931\u20137.","journal-title":"Neurology"},{"key":"624_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1634\/theoncologist.11-3-292","volume":"11","author":"JW Beukelaar De","year":"2006","unstructured":"De Beukelaar JW, Sillevis Smitt PA. Managing paraneoplastic neurological disorders. Oncologist. 2006;11:292\u2013305.","journal-title":"Oncologist"},{"key":"624_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/brain\/awg133","volume":"126","author":"S Shams\u2019ili","year":"2003","unstructured":"Shams\u2019ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, Vecht C, Sillevis Smitt P. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003;126:1409\u201318.","journal-title":"Brain."},{"key":"624_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3892\/ol.2012.1016","volume":"5","author":"AE Russo","year":"2013","unstructured":"Russo AE, Scalcone S, Leonardi GC, Scalisi A, Giorda G, Sorio R. Paraneoplastic cerebellar degeneration associated with ovarian cancer. Oncol Lett. 2013;5:681\u20133.","journal-title":"Oncol Lett"},{"key":"624_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","volume":"15","author":"H Mitoma","year":"2016","unstructured":"Mitoma H, Adhikari K, Aeschlimann D, Chattopadhayay P, Hadijvassiliou M, Hampe CS, Honnorat J, Joubert B, Kakaei S, Lee J, Manto M, Matsunaga A, Mizusawa H, Nanri K, Shanmugarajah P, Yoneda M, Consensus Paper YN. Neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15:213\u201332.","journal-title":"Cerebellum"},{"key":"624_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1212\/WNL.0b013e31820d62eb","volume":"76","author":"C Briani","year":"2011","unstructured":"Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC, et\u00a0al. Spectrum of paraneoplastic disease associated with lymlphoma. Neurology. 2011;76:705\u201310.","journal-title":"Neurology"},{"issue":"12","key":"624_CR17","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.apmr.2014.07.003","volume":"95","author":"JB Fu","year":"2014","unstructured":"Fu JB, Raj VS, Asher A, Lee J, Guo Y, Konzen BS, Bruera E. Inpatient rehabilitation performance of patients with paraneoplastic cerebellar degeneration. Arch Phys Med Rehabil. 2014;95(12):2496\u20139.","journal-title":"Arch Phys Med Rehabil"},{"issue":"8","key":"624_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Bilings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N\u00a0Engl J Med. 2010;363(8):733\u201342.","journal-title":"N Engl J Med"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-018-0624-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-018-0624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-018-0624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T19:44:17Z","timestamp":1549395857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-018-0624-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":18,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1007\/s10354-018-0624-4","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"type":"print","value":"0043-5341"},{"type":"electronic","value":"1563-258X"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"19 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.\u00a0Burger und S.\u00a0Lorenzl geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}